Crossref
Balancing the Risks and Benefits of GLP-1 Agonists for Weight Loss
Biology, Engineering, Medicine and Science Reports · 2024
DOI: 10.5530/bems.10.2.9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology, Engineering, Medicine and Science Reports, 2024. Verfasst von Arun HS Kumar. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kumar, A. H. (2024). Balancing the Risks and Benefits of GLP-1 Agonists for Weight Loss. Biology, Engineering, Medicine and Science Reports. https://doi.org/10.5530/bems.10.2.9
Vancouver
Kumar AH. Balancing the Risks and Benefits of GLP-1 Agonists for Weight Loss. Biology, Engineering, Medicine and Science Reports. 2024. doi:10.5530/bems.10.2.9
BibTeX
@article{Kumar2024,
author = {Kumar, Arun HS},
title = {Balancing the Risks and Benefits of GLP-1 Agonists for Weight Loss},
journal = {Biology, Engineering, Medicine and Science Reports},
year = {2024},
doi = {10.5530/bems.10.2.9}
}
EUVIMED